Resveratrol also candidate for hormone replacement and breast cancer prevention

This study now being published in The Journal of Nutritional Biochemistry details the exceptional ability of resveratrol to stimulate estrogen receptors in a way that can alleviate the effects of estrogen deficiency while at the same time protecting against breast cancer. We have been using a laboratory-certified form of reseveratol for its previously documented effects on insulin, leptin and glucose regulation (it has also extended the lifespan of lab animals—it's the component in red wine that has been well-publicized). The authors state: "Thus, resveratrol might be the most promising candidate for HRT and chemoprevention of breast cancer due to its estrogenic activity and high antitumor activity."